Comparative pharmacokinetics of antipyrine (phenazone) in the baboon, cynomolgus monkey and rhesus monkey
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 19 (2) , 159-168
- https://doi.org/10.1016/0300-483x(81)90097-4
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Comparison of rate of Hepatic Metabolismin vitroand Half-Life for Antipyrinein vivoin Three SpeciesXenobiotica, 1979
- The Role of Glutathione and Glutathione S-Transferases in the Metabolism of Chemical Carcinogens and Other Electrophilic AgentsAdvances in Cancer Research, 1979
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Species variations in the pathways of drug metabolism.Environmental Health Perspectives, 1978
- Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urineClinical Pharmacology & Therapeutics, 1975
- Inter-Species Variations in the Metabolism of XenobioticsBiochemical Society Transactions, 1974
- Increased Clearance of Antipyrine and d-Propranolol after Phenobarbital Treatment in the MonkeyJournal of Clinical Investigation, 1974
- Implications of enzyme induction in drug toxicity studiesToxicology and Applied Pharmacology, 1967
- Species, strain and sex differences in metabolism of hexobarbitone, amidopyrine, antipyrine and anilineBiochemical Pharmacology, 1958
- THE DISTRIBUTION OF RANGE IN SAMPLES FROM A NORMAL POPULATION, EXPRESSED IN TERMS OF AN INDEPENDENT ESTIMATE OF STANDARD DEVIATIONBiometrika, 1939